Tag: sales

Pharmaceutical and Biotechnology Industry Representatives File Lawsuit Over Nevada’s Prescription Drug Transparency Bill *UPDATED*

On September 1, 2017, Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization (collectively “Plaintiffs”) filed a complaint (the “Lawsuit”) in the United States District Court for the District of Nevada, against Brian Sandoval, in his official capacity as the Governor of the State of Nevada, and Richard Whitley […]

Nevada Enacts Transparency Bill Targeting Diabetes Drug Price Increases, Sales Representatives, PBMs, Nonprofit Organizations

As we discussed last week, Nevada’s Governor has signed into law SB 539, which provides sweeping transparency legislation related to several aspects of the pharmaceutical industry. Nevada joins several other states in adopting legislation aimed at addressing pharmaceutical price increases and other recent industry concerns. Diabetes Drug Pricing Reports February […]

FDA Revises Draft Reprint Guidance: Includes New Recommendations for Clinical Practice Guidelines

In today’s Federal Register, the U.S. Food and Drug Administration (“FDA”) announced the availability of a revised draft guidance document titled: “Distributing Scientific and Medical Publications on Unapproved New Uses – Recommended Practices” (the “Revised Draft Reprint Guidance”).  This revises the FDA’s 2009 draft guidance document on the subject, which was […]

Law360 Article: “GSK Announcement May Change Industry Speaker Programs”

As we previously posted, GlaxoSmithKline (GSK) recently announced that it intends to end the practice of paying health care professionals to speak on the company’s behalf in a promotional manner.  While GSK was the first pharmaceutical company to announce this change, other pharmaceutical and medical device manufacturers may be considering similar changes.  […]

GSK Will Stop Paying HCP Speakers, Expanding Sales Rep Compensation Structure Globally

GlaxoSmithKline (GSK) announced this week that it will stop compensating health care professionals (HCPs) for speaking on the company’s behalf regarding its products and related disease areas to other HCPs and attendees who potentially could prescribe or influence the prescribing of the company’s products.  GSK also announcenced its intent to educate HCPs by strengthening its own medical and scientific capabilities, improving the company’s multi-channel capability to provide appropriate and convenient […]